GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression
GPR55 recognizes several lipid molecules such as lysophosphatidylinositol. GPR55 expression was reported in human monocytes. However, its role in monocyte adhesion and atherosclerosis development has not been studied. The role of GPR55 in monocyte adhesion and atherosclerosis development was investi...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/23/13084 |
_version_ | 1797507701195931648 |
---|---|
author | Seung-Jin Lee Dong-Soon Im |
author_facet | Seung-Jin Lee Dong-Soon Im |
author_sort | Seung-Jin Lee |
collection | DOAJ |
description | GPR55 recognizes several lipid molecules such as lysophosphatidylinositol. GPR55 expression was reported in human monocytes. However, its role in monocyte adhesion and atherosclerosis development has not been studied. The role of GPR55 in monocyte adhesion and atherosclerosis development was investigated in human THP-1 monocytes and ApoE<sup>−/−</sup> mice using O-1602 (a potent agonist of GPR55) and CID16020046 (a specific GPR55 antagonist). O-1602 treatment significantly increased monocyte adhesion to human umbilical vein endothelial cells, and the O-1602-induced adhesion was inhibited by treatment with CID16020046. O-1602 induced the expression of Mac-1 adhesion molecules, whereas CID16020046 inhibited this induction. Analysis of the promoter region of <i>Mac-1</i> elucidated the binding sites of AP-1 and NF-κB between nucleotides −750 and −503 as GPR55 responsive elements. O-1602 induction of Mac-1 was found to be dependent on the signaling components of GPR55, that is, Gq protein, Ca<sup>2+</sup>, CaMKK, and PI3K. In Apo<sup>−/</sup><sup>−</sup> mice, administration of CID16020046 ameliorated high-fat diet-induced atherosclerosis development. These results suggest that high-fat diet-induced GPR55 activation leads to the adhesion of monocytes to endothelial cells via induction of Mac-1, and CID16020046 blockage of GPR55 could suppress monocyte adhesion to vascular endothelial cells through suppression of Mac-1 expression, leading to protection against the development of atherosclerosis. |
first_indexed | 2024-03-10T04:52:10Z |
format | Article |
id | doaj.art-4bd20e0282a94b1e95105b69aa866ce2 |
institution | Directory Open Access Journal |
issn | 1661-6596 1422-0067 |
language | English |
last_indexed | 2024-03-10T04:52:10Z |
publishDate | 2021-12-01 |
publisher | MDPI AG |
record_format | Article |
series | International Journal of Molecular Sciences |
spelling | doaj.art-4bd20e0282a94b1e95105b69aa866ce22023-11-23T02:32:58ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-12-0122231308410.3390/ijms222313084GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 ExpressionSeung-Jin Lee0Dong-Soon Im1Department of Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, KoreaEast West Pharmaceutical Research Center, Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02447, KoreaGPR55 recognizes several lipid molecules such as lysophosphatidylinositol. GPR55 expression was reported in human monocytes. However, its role in monocyte adhesion and atherosclerosis development has not been studied. The role of GPR55 in monocyte adhesion and atherosclerosis development was investigated in human THP-1 monocytes and ApoE<sup>−/−</sup> mice using O-1602 (a potent agonist of GPR55) and CID16020046 (a specific GPR55 antagonist). O-1602 treatment significantly increased monocyte adhesion to human umbilical vein endothelial cells, and the O-1602-induced adhesion was inhibited by treatment with CID16020046. O-1602 induced the expression of Mac-1 adhesion molecules, whereas CID16020046 inhibited this induction. Analysis of the promoter region of <i>Mac-1</i> elucidated the binding sites of AP-1 and NF-κB between nucleotides −750 and −503 as GPR55 responsive elements. O-1602 induction of Mac-1 was found to be dependent on the signaling components of GPR55, that is, Gq protein, Ca<sup>2+</sup>, CaMKK, and PI3K. In Apo<sup>−/</sup><sup>−</sup> mice, administration of CID16020046 ameliorated high-fat diet-induced atherosclerosis development. These results suggest that high-fat diet-induced GPR55 activation leads to the adhesion of monocytes to endothelial cells via induction of Mac-1, and CID16020046 blockage of GPR55 could suppress monocyte adhesion to vascular endothelial cells through suppression of Mac-1 expression, leading to protection against the development of atherosclerosis.https://www.mdpi.com/1422-0067/22/23/13084GPR55CID16020046atherosclerosismonocyte adhesionMac-1 |
spellingShingle | Seung-Jin Lee Dong-Soon Im GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression International Journal of Molecular Sciences GPR55 CID16020046 atherosclerosis monocyte adhesion Mac-1 |
title | GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression |
title_full | GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression |
title_fullStr | GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression |
title_full_unstemmed | GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression |
title_short | GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression |
title_sort | gpr55 antagonist cid16020046 protects against atherosclerosis development in mice by inhibiting monocyte adhesion and mac 1 expression |
topic | GPR55 CID16020046 atherosclerosis monocyte adhesion Mac-1 |
url | https://www.mdpi.com/1422-0067/22/23/13084 |
work_keys_str_mv | AT seungjinlee gpr55antagonistcid16020046protectsagainstatherosclerosisdevelopmentinmicebyinhibitingmonocyteadhesionandmac1expression AT dongsoonim gpr55antagonistcid16020046protectsagainstatherosclerosisdevelopmentinmicebyinhibitingmonocyteadhesionandmac1expression |